Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 12, Pages 483
Publisher
MDPI AG
Online
2018-12-04
DOI
10.3390/cancers10120483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- Improving combination cancer therapy: the CombiPlex® development platform
- (2018) Anthony W Tolcher et al. Future Oncology
- Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
- (2018) Douae Bensaid et al. Clinical Epigenetics
- Rationalizing combination therapies
- (2017) NATURE MEDICINE
- DNA methylation at enhancers identifies distinct breast cancer lineages
- (2017) Thomas Fleischer et al. Nature Communications
- Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma
- (2017) Yaqin Zhang et al. Cell and Bioscience
- BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
- (2017) Sergey Karakashev et al. Cell Reports
- Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
- (2017) Ravi Doddapaneni et al. Scientific Reports
- The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
- (2016) KAROLINA LAPINSKA et al. ANTICANCER RESEARCH
- Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth
- (2016) R. Pathania et al. CANCER RESEARCH
- Two is better than one; toward a rational design of combinatorial therapy
- (2016) Sheng-hong Chen et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
- (2016) Mckenna Longacre et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tissue-specific mutation accumulation in human adult stem cells during life
- (2016) Francis Blokzijl et al. NATURE
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- Chromosomal Loop Domains Direct the Recombination of Antigen Receptor Genes
- (2015) Jiazhi Hu et al. CELL
- Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer
- (2015) A. K. Singh et al. CLINICAL CANCER RESEARCH
- Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
- (2015) Dmitri Pchejetski et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
- (2015) Ryan B. Corcoran et al. JOURNAL OF CLINICAL ONCOLOGY
- PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
- (2015) Ana Bosch et al. Science Translational Medicine
- Telomere-Homologous G-Rich Oligonucleotides Sensitize Human Ovarian Cancer Cells to TRAIL-Induced Growth Inhibition and Apoptosis
- (2015) Sibaji Sarkar et al. Nucleic Acid Therapeutics
- HDAC inhibitors and immunotherapy; a double edged sword?
- (2015) Michiel Kroesen et al. Oncotarget
- Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients
- (2014) M. Tassara et al. BLOOD
- New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer
- (2014) P. M. Forde et al. CLINICAL CANCER RESEARCH
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
- (2014) Ercan Cacan et al. PLoS One
- Do epigenetic drug treatments hold the key to killing cancer progenitor cells?
- (2014) Shannon Byler et al. Epigenomics
- Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
- (2014) Daniela Luvero et al. Therapeutic Advances in Medical Oncology
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Cancer Development, Progression, and Therapy: An Epigenetic Overview
- (2013) Sibaji Sarkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
- (2013) Byram W Bridle et al. MOLECULAR THERAPY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation
- (2013) C. Tomasetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic Driver Mutations: Neither Tissue-Specific nor Independent
- (2013) A. A. Margolin Science Translational Medicine
- Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy
- (2013) Sibaji Sarkar et al. Epigenomics
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
- (2012) Piro Lito et al. CANCER CELL
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors
- (2012) A. B. Turke et al. CANCER RESEARCH
- Therapeutic strategies in epithelial ovarian cancer
- (2012) Ayako Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- (2012) Swen Hoelder et al. Molecular Oncology
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- A Blueprint for Advancing Genetics-Based Cancer Therapy
- (2011) William R. Sellers CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- T-Oligos Inhibit Growth and Induce Apoptosis in Human Ovarian Cancer Cells
- (2011) Sibaji Sarkar et al. OLIGONUCLEOTIDES
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
- (2011) Gina Mantia-Smaldone et al. Cancer Management and Research
- Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells
- (2010) Anne-Sophie Belanger et al. BMC MOLECULAR BIOLOGY
- Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
- (2010) N. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF- IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
- (2010) Z. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
- (2009) D. Lesniak et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K
- (2009) P Maier et al. GENE THERAPY
- Epigenetic biomarker development
- (2009) Christoph Bock Epigenomics
- Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells
- (2008) B. C. Fuchs et al. CANCER RESEARCH
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
- (2008) Kathy S. Albain et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
- (2008) A. J. Frew et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now